Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Life Insurance Co ( (HK:2628) ) just unveiled an update.
China Life Insurance Company Limited has announced the renewal of its framework agreement with AMP, allowing for continued daily transactions such as the subscription and redemption of fund products and private asset management. These transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, with specific exemptions from independent shareholder approval due to the applicable percentage ratios. This renewal is expected to maintain operational continuity and compliance with regulatory requirements, impacting the company’s financial dealings and strategic partnerships.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major player in the insurance industry, primarily offering life insurance products and services. The company is focused on the Chinese market and operates with a significant shareholding structure, with CLIC as its controlling shareholder.
Average Trading Volume: 76,790,120
Technical Sentiment Signal: Buy
Current Market Cap: HK$1217B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.